We work with compassion and commitment in making a difference in the lives of patients
Get In Touch
We partner with companies globally to introduce innovations in Asia in the areas of speciality treatments
Get In Touch
We continuously look for opportunities for successful collaborations to bridge therapies to patients
Get In Touch

AxxessBio is a distributor of pharmaceutical products incorporated in Singapore in 2011 by professional executives in the biotech and pharmaceutical industries.

AxxessBio partners with companies globally to introduce innovations in Asia in the areas of speciality treatments.

We actively look for therapeutic solutions particularly in the areas of Hematology, Oncology, Neonatology, Rare Diseases, Metabolic Diseases and Other Speciality Therapeutics. Read more.

【Special Offer】Rolex Submariner 116610LN Automatic Men’s WatchReplica Watches Store with Diamonds and Blue Plate .


AxxessBio creates a fully integrated solution to ensure AccessiBility of your life-changing therapies

AxxessBio Partners

Our Market Access Model

At AxxessBio, we bring the right treatments at the right time

By partnering with us, we develop a market access program to ensure your innovative therapies are made accessible to patients

Early access to Patients

We bring your innovative therapies to patients on an expedited basis prior to registration 

Timely access to Market

We ensure timely access to market through an integrated solution

Sustained access to Funding

We support patients to obtain funding for treatment 

Latest News and Releases

AxxessBio and PTC Therapeutics introduce Translarna™ for Duchenne muscular dystrophy and Upstaza™ for AADC Deficiency in Southeast Asia

On 1st November 2023, PTC Therapeutics International Limited, granted exclusive distribution rights to AxxessBio in several countries in Southeast Asia for Translarna™ (ataluren) and a service agreement for Upstaza™ (eladocagene exuparvovec). Translarna™ is indicated for the treatment of Duchenne muscular dystrophy (DMD), resulting from a nonsense mutation in the dystrophin

Read More »

Interested in Partnering Up?

At AxxessBio, we are continuously looking for partnerships to bring new innovative therapies for patients all around Asia